All News

Prepare to counsel patients on microbiome-related products.

The Federal Vaccine Consultation Panel will allow industry leaders to share the questions, concerns, and needs of their constituencies related to the development and distribution planning of a COVID-19 vaccine.

The AZD1222 vaccine, made from a common cold virus present in chimpanzees, produced rapid neutralizing antibody levels against the SARS-CoV-2 virus.

The Oklahoma Board of Pharmacy fined CVS Health $125,000 after receiving multiple complaints about errors and overwhelmed staff members.

Once largely stigmatized, illicit substances are breaking into the field of pain management.

Pfizer and BioNTech SE announced that 2 of its most successful vaccine candidates received Fast Track designation from the FDA, opening the avenue for speedy development.

Enhanced pharmacy services such as home delivery, curbside services, and expanded personal patient outreach create opportunities to address social determinants of health during the pandemic.

Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.

The American Cancer Society has updated its guidelines regarding the administration of the HPV vaccine.

NACDS is urging the Drug Enforcement Administration to make electronic prescriptions for controlled substances mandatory.

Kroger Health will start offering its COVID-19 Test Home Collection Kit with the guidance of a telehealth consultation.

The CDC has identified the pharmacy sector as a key partner in offering its lifestyle change-based program for patients with high risk for type 2 diabetes.

A collaboration between APhA and PTCB will help provide pharmacy technician credentialing in immunization delivery.

A Johns Hopkins research team has determined that tests are more likely to result in false negatives for the COVID-19 virus if taken too early in the course of infection.

In a new guidance, the FDA provides recommendations for those developing COVID-19 vaccines to ensure safety and efficacy.

An updated list of risk factors for severe COVID-19 expands possible underlying medical conditions and removes the age threshold.

Through the print publication and a growing digital footprint, Drug Topics® provides a dynamic range of content across the pharmaceutical spectrum.

Vaccine candidates for COVID-19 are going through clinical trials at a faster rate than for any other disease.

Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).

The MMR vaccine may demonstrate some degree of protection against septic inflammation, a symptom of COVID-19, according to a team of experts.

Results of a PLOS ONE study determined a positive relationship between COPD and smoking and mortality rates from COVID-19.

A new poll by Gallup and West Health found that a majority of Americans have expressed numerous health care system-related concerns, including rising costs of drugs, insurance premiums, and health care in response to COVID-19.

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.

Here's a roundup of this week's coronavirus-related news.

As reopening efforts and recovery plans start to take hold, it should be recognized that community pharmacies are ideally positioned to support this national effort.

EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.